To assess the prevalence of bovine viral diarrhea virus (BVDV) on the basis of the genotype and clinical signs, isolates from 16 dairy herds (bulk milk samples) and 37 BVDV-infected cattle were examined. Isolates for this study were selected from submissions that contained an adequate clinical history. A part of the E2 gene of BVDV from these isolates was amplified by reverse transcription-polymerase chain reaction. From the nucleotide sequence of the amplified products, phylogenetic analyses were performed and genotypes or subgenotypes were identified. Forty percent of the selected field isolates were BVDV-2, and 60% were BVDV-1. Eighty-one percent of BVDV-1 isolates were determined to be the BVDV-1b subgenotype. BVDV-1b and BVDV-2 formed more closely related clusters in each group than did the BVDV-1a isolates. There was no obvious association of any genotype or subgenotype with geographical localization or clinical manifestations. A higher prevalence of BVDV-2 infection was found in the United States than in other countries. BVDV-1a has been thought of as a prototype of BVDV; however, there were fewer isolations of BVDV-1a than of other subgenotypes of BVDV. Phylogenetic analyses of BVDV isolates using the E2 region of the genome generated results similar to those of studies done in the United States using the 5Ј untranslated region.
Introduction
Bovine viral diarrhea virus (BVDV) is a pathogen that is distributed worldwide in domestic animal and wildlife populations. Infection of animals by BVDV can produce clinical signs ranging from subclinical to severe affecting respiratory and gastrointestinal systems. It is the causative agent of the complex syndrome bovine viral diarrhea-mucosal disease. Immunotolerance against BVDV caused by in utero infection plays an important role in the epidemiology of BVDV. 7 Persistently infected cattle spread the virus in the herd in many cases without typical clinical manifestations. Respiratory problems, poor production performance, and reproductive problems are usually seen in BVDV-infected cattle herds. 1 Elucidation of the relationship between antigenic diversity of BVDV and clinical manifestations in infected cattle may be helpful in understanding the pathogenicity of BVDV.
Since the identification of the BVDV-2 genotype, 18, 21 which was isolated from cattle exhibiting peracute signs of respiratory distress and severe diarrhea and in some instances uncontrolled hemorrhage, BVDV isolates have been classified based on nucleotide sequences of the viral genome. Genotyping is usu-From the Veterinary Teaching Hospital, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan (Tajima) , and the Department of Population Medicine and Diagnostic Sciences, Diagnostic Laboratory, College of Veterinary Medicine, Cornell University, Ithaca, NY 14852-5786 (Dubovi). 1 Corresponding Author: Motoshi Tajima, Veterinary Teaching Hospital, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan. ally based on phylogenetic analysis of the nucleotide sequences of the 5Ј untranslated region (5ЈUTR) of the viral genome. 3, 10, 11, 16, 17, 20, 23, 29, 30 The antigenic relatedness among the genotypes or subgenotypes has been estimated using monoclonal antibodies. 21, 29 The antigenicity of BVDV is largely dependent on the E2 antigen. The diversity of the E2 gene has also been used to define the genotypes of BVDV isolates. Data on the variation of E2 may be useful in the analysis of pathogenicity. 4, 24, 28 There are many reports concerning the genotyping of BVDV isolates, and some of these reports have focused on the geographical distribution of BVDV. 3, 4, 10, 11, 16, 17, 20, 23, 24, [28] [29] [30] In this study, recently identified BVDV field isolates were analyzed phylogenetically using the genetic diversity of the E2 gene of BVDV amplified by reverse transcription-polymerase chain reaction (RT-PCR). The prevalence of different genotypes of BVDV arising from dairy herds in the United States is reported.
Materials and methods
Viruses. Fifty-three viruses isolated from dairy herds between 1998 and 2001 from diagnostic samples originating from 16 states of the United States were selected for study. Except for samples from California (1 isolate-1 herd), Colorado (2 isolates-1 herd), Kansas (4 isolates-1 herd), and Texas (3 isolates-1 herd), the samples were from 12 states in the eastern region of the United States. Isolate selection was based on the inclusion of some animal or herd history with the sample. Thus, the selection of this subset of isolates was determined by the character of the veterinarian and not by a selection scheme at the laboratory level. In this context, Gi-6 Panama AF144612 Figure 1 . Phylogenetic tree constructed from 420 nucleotides of the E2 glycoprotein gene of 61 BVDV. The numbers adjacent to the major nodes refer to bootstrapping confidence levels. The sequences indicated by name in the tree were taken from the GenBank data library, except for CD87 and NVSL125. Bar indicates 0.1 nucleotide substitutions per site. the samples might be considered random. A noncytopathogenic strain isolated from naturally infected cattle in 1987 (CD87) 9 and the cytopathogenic American type strain NVSL 125 were used as reference strains of BVDV-2. Also 3 field isolates (a58-60), which were isolated between 1987 and 1995 and identified as BVDV-2, were used for the comparison.
Reverse transcription-polymerase chain reaction. Viral RNA was extracted from the culture supernatant of Madin-Darby bovine kidney cells used for virus propagation. A commercial kit was used for the extraction of viral RNA according to the manufacturer's instructions. a Synthesis of complementary DNA (cDNA) was carried out using Moloney murine leukemia virus reverse transcriptase and random hexamer. 25 Amplification of cDNA by PCR was carried out in a total volume of 100 l in reaction buffer for Taq polymerase b supplemented with 2.5 U of Taq polymerase, b 50 pmol of each primer, 0.2 mM deoxynucleoside triphosphates, and 2 l of cDNA. Specific primers for the E2 gene 24 were used for amplification. Amplification was performed with 35 cycles of denaturation at 95 C for 1 min, annealing at 55 C for 1 min and extension at 72 C for 1 min. After amplification, the PCR products were characterized by 1.5% agarose gel electrophoresis in Tris-acetic acid-ethylenediaminetetraacetic acid buffer.
Nucleotide sequencing. The PCR products were purified and concentrated using a commercial kit. c The nucleotide sequences of the amplification products were determined with an automated DNA sequencer d using a sequencing kit according to the manufacturer's protocol. e At least 3 amplified products were sequenced for confirmation. Each PCR product was sequenced using at least 2 different sequencing primers reported previously. 24 As reference sequences for the grouping of genotypes, the corresponding E2 sequences from some additional BVDV isolates were obtained from the GenBank data library (Table 1) .
Phylogenetic analysis. The nucleotide sequences were proofread using the computer program GENETYX-MAC. f The 420-bp fragments of the E2-coding region of each sam-ple were used for phylogenetic analysis. This region (nucleotide numbers 2879-3298 of NADL strain) included the coding sequence of an epitope of E2. 26 The sequences were aligned using the CLUSTALX version 1.8 program. The transition/transversion rates were calculated using the PU-ZLE 4.0.2 program. Bootstrapping values were calculated using the modules SEQBOOT (random number seed: 123; 100 replicates), DNADIST (distance estimation: maximum likelihood; analysis of 100 data sets), NEIGHBOR (UPGMA method; random number seed: 99; analysis of 100 data sets), and CONSENSE from the PHYLIP package. g The phylogenetic trees were computed with DNADIST and NEIGH-BOR modules with the same parameters as above. For visualization of the trees, the tree drawing software TREEV-IEW was used. h
Results
Genotyping of BVDV field isolates. Thirty-two of the selected field isolates were found to have the BVDV-1 genotype and 21 isolates the BVDV-2 genotype ( Fig. 1 ). Twenty-six of 32 BVDV-1 isolates were classified in the BVDV-1b subgenotype by phylogenetic analysis. These 1b isolates constituted a close cluster including the CP7 and NY-1 strains. Six of 32 BVDV-1 isolates were classified in the BVDV-1a subgenotype. The BVDV-1a subgenotype including prototype laboratory strains (NADL, SD-1, and Singer) was a looser cluster than the BVDV-1b cluster. Twenty-one isolates of BVDV-2 were classified in the BVDV-2a subgenotype (Fig. 2) . The reference strains of BVDV-2 (890, CD87, and NVSL125) were included in the 2a cluster. The cluster of the BVDV-2 ge- notype was genetically closer than that of BVDV-1 ( Fig. 1) .
Clinical features of BVDV-1 infection. The details of the field isolates classified as BVDV-1 are described in Table 2 . The clinical manifestations recognized in BVDV-1a-infected cattle (6 cases) were diarrhea (3 cases), respiratory disorder (2 cases), and poor doers (1 case). Two isolates (A35 and A36) detected from individual cattle raised at different farms (New York and Indiana) had identical nucleotide sequences of the E2 gene. They manifested watery diarrhea and severe pneumonia, respectively.
BVDV-1b-infected cattle (26 cases) exhibited diarrhea (7 cases), abortion (5 cases), poor doers (4 cases), and respiratory signs (3 cases). In 1 BVDV-1b-infected calf (A56), thrombocytopenia (15,000 platelets/l blood) and hematoma were recognized.
Clinical features of BVDV-2 infection. The details of the field isolates classified as BVDV-2 are described in Table 3 . Four older BVDV-2 isolates (a58-60 and a62) from cattle affected by a severe outbreak or hemorrhagic syndrome were classified in the BVDV-2a subgenotype. In this study, hemorrhagic syndrome was recognized in 2 cases (a41 and a55) among 21 BVDV-2a-infected cattle. The other clinical manifestations recognized in BVDV-2a-infected cattle were respiratory signs or pneumonia (4 cases), acute or chronic diarrhea (5 cases), abortion (2 cases), and diarrhea and respiratory signs (5 case).
Seven isolates of BVDV-2a were detected in bulk tank milk during a check of BVDV infection in herds. Two of these isolates (a45 and a46) were detected in individual bulk tank milk samples from the same farm. In addition, a BVDV-1b (A47) was isolated from another bulk tank milk sample from the same farm. In this farm, at least 3 strains of BVDV, including genotypes 1 and 2, existed in the dairy herd. The presenting problem of this farm was poor conception rate with abortion episodes. A similar situation was found on another large dairy where 4 BVDV isolates represented BVDV-1b and BVDV-2a genotypes (A17, A18, a19, and a20).
Discussion
Forty percent of the field isolates of BVDV from dairy herds examined in this study were BVDV-2. Although these isolates are not truly representative of all isolates made at the laboratory during this period of time, the percentage of BVDV-2 isolates is remarkably similar to reports from the south central and western part of the United States. 11, 13 BVDV-2 seems to be more prevalent in the United States than in the other countries. The typical manifestations of BVDV-2 infection were initially thought to be a hemorrhagic syndrome or peracute severe outbreak (prototype BVDV-2). 6, 8, 11, 15, 18, 19 Only 2 cases exhibited such typical symptoms, as shown in Table 3 . All isolates including prototype strains that caused these clinical signs were classified in the BVDV-2a subgenotype. It is now clear that severe disease is not inextricably linked to the type 2 genotype and that many type 2 infections pass as subclinical infections.
In retrospective studies, the linking of genotypes and clinical signs is complicated by the fact that many of the test samples come from persistently infected animals or animals strongly suspected of being persistently infected. In these cases, the clinical manifestations may have little to do with the BVDV infection per se. The inability of persistently infected animals to handle normal bovine pathogens can result in clinical presentations more closely linked to the secondary pathogen than to the BVDV infection. In addition, some of the animals may be showing signs of mucosal disease, which could be confused with peracute BVDV. This was the case for A56 ( Table 2 ). This BVDV-1b genotype seemed to be inducing signs similar to BVDV-2 infections. However, this isolate came from a calf that was persistently infected and died of mucosal disease 5 months after its detection. Currently, there are no diagnostic tests that can definitively define a persistently infected animal on a single test. If a link is to be made between genotype and clinical disease, either experimental or prospective studies will have to be done.
Six isolates with the BVDV-1 genotype in this study were subclassified into the BVDV-1a subgenotype and 26 BVDV-1 isolates into the BVDV-1b subgenotype. BVDV-1b can be divided into the 1b1 and 1b2 subgenotypes using the E2 gene for sequence analysis. Thirty German field isolates identified as BVDV-1b were subclassified into 1b1 (22 isolates) and 1b2 (8 isolates) clusters. 24 Except for A27, almost all American BVDV-1b isolates identified in this study were classified as BVDV-1b2 (Figs. 1, 2) . The prototype American BVDV-1b strains such as CP-7 and NY-1 were classified as 1b2, whereas the prototype European BVDV-1b strain (Osloss) was classified as 1b1. As shown in Fig. 1 , the predominant prevalence of BVDV-1b2 is thought to be a distinctive feature of BVDV infection in the United States. It is interesting to note the relatively small change in BVDV-1b2 isolates during a 50-year period (NY-1 isolated in 1949). It was reported that BVDV-1b is closely involved in the manifestation of respiratory disorders. 2, 13, 20 In this study, no significant association of this subgenotype with respiratory signs was detected. Sixteen isolates of BVDV were obtained from bulk tank milk during checks for BVDV infection in dairy herds. The rates of detection of BVDV-1 and -2 were almost the same: 9 and 7 strains, respectively. In 1 farm in Texas (Ͼ3,000 lactating animals), 2 BVDV-2a isolates (a45 and a46) and 1 BVDV-1b isolate (A47) were obtained from an individual bulk tank. The problem on this farm was ongoing conception rate problems. In another farm in Kansas (4,800 lactating animals), 2 BVDV-1b (A17 and A18) and 2 BVDV-2a (a19 and a20) isolates were detected. No specific problem was identified on this farm because the viruses were detected during the procedures for implementing a production medicine program on this farm. These 2 farms clearly demonstrate that in large production fa- cilities there can be multiple introductions of BVDV and that vaccine programs must anticipate all current circulating genotypes of BVDV. Prototype BVDV-1a strains such as NADL and Singer have been used in vaccines to prevent BVDVinduced diseases. 5, 27 In this study, only a few field isolates were classified as BVDV-1a. It has been reported that BVDV-1a vaccine was also effective against other genotypes of BVDV. 5, 22 As shown in Fig. 1 , more BVDV-1b and -2 were detected than BVDV-1a. Almost the same results have been reported concerning BVDV field isolates detected in the northwestern United States. 11 It is not clear whether in this study the low proportion of BVDV-1a field isolates was due to an effect of vaccination. However, one must be very careful in inferring an impact of vaccination on genotype prevalence. The authors currently have very little data on the genotypes of BVDV circulating before the introduction of vaccines. In point of fact, of the 4 oldest isolates of BVDV currently available, 3 are BVDV-1b (NY-1, Osloss, and C-60F; Dubovi, unpublished data) and 1 is a BVDV-1a (C24V).
As with most RNA viruses, BVDV shares the characteristic of having a replication system that makes frequent errors. This property could make genotyping somewhat problematic depending on the sequences chosen for study. Remarkably, the major genotype delineations for BVDV seem to be independent of the genomic sequence analyzed. In this study as well as others, the E2 gene 4,24,28 was used, whereas other groups have used 5ЈUTR, 11, 12, 14, 18, 21, 29, 30 NS2/3, 12 and N pro . 4 In all these studies regardless of sequence analyzed, the major type strains of BVDV have been assigned the same genotype. As has been noted previously, 12 these results strongly suggested that BVDV-1 and BVDV-2 viruses have been evolving separately and vaccination has not generated the heterogeneity within the BVDV isolates.
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